Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer
暂无分享,去创建一个
A. Dicker | P. Anné | R. Axelrod | D. Cognetti | W. Keane | E. Wuthrick | P. Ahn | M. Machtay